Stock Events

Stock Events

HLS Therapeutics (HLTRF) Q1 2025 Earnings

13MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.19

-0.16

-0.12

-0.09

Details

Expected EPS

-0.088375

Actual EPS

-0.1

Surprise EPS

-0.01

Surprise Percent

+13.15%

Description

HLS Therapeutics (HLTRF) has reported earnings of -0.1 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.